Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J D Wallis

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
The Journal of Urology|August 7, 2017
Editorial CommentChristopher J D Wallis
The Journal of Urology|December 12, 2017
Editorial CommentChristopher J D Wallis
The Journal of Urology|September 9, 2025
Editorial CommentClare O'Connell, Christopher J D Wallis
The Journal of Urology|August 16, 2021
Editorial CommentChristopher J D Wallis, Zachary Klaassen
Nature Reviews. Urology|December 30, 2016
Prostate cancer: Risk factors - you find what you are looking forChristopher J D Wallis, Raj Satkunasivam
The Journal of Urology|September 6, 2022
Editorial CommentChristopher J D Wallis, Zachary Klaassen
European Urology Oncology|May 18, 2019
"Reverse Stage Migration": What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?Christopher J D Wallis, Zachary Klaassen
Urology|July 4, 2016
Author ReplyChristopher J D Wallis, Raj Satkunasivam
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101Christopher J D Wallis, Zachary Klaassen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 5, 2019
Optimizing management of patients with microhematuria: Gold down the drain?Christopher J D Wallis, Zachary Klaassen
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
The Journal of Urology|August 7, 2017
Editorial CommentChristopher J D Wallis
The Journal of Urology|December 12, 2017
Editorial CommentChristopher J D Wallis
The Journal of Urology|September 9, 2025
Editorial CommentClare O'Connell, Christopher J D Wallis
The Journal of Urology|August 16, 2021
Editorial CommentChristopher J D Wallis, Zachary Klaassen
Nature Reviews. Urology|December 30, 2016
Prostate cancer: Risk factors - you find what you are looking forChristopher J D Wallis, Raj Satkunasivam
The Journal of Urology|September 6, 2022
Editorial CommentChristopher J D Wallis, Zachary Klaassen
European Urology Oncology|May 18, 2019
"Reverse Stage Migration": What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?Christopher J D Wallis, Zachary Klaassen
Urology|July 4, 2016
Author ReplyChristopher J D Wallis, Raj Satkunasivam
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101Christopher J D Wallis, Zachary Klaassen
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 5, 2019
Optimizing management of patients with microhematuria: Gold down the drain?Christopher J D Wallis, Zachary Klaassen
Pageof 33